P. Martin Paslick - Jan 23, 2023 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
SVP and CIO
Signature
/s/ Natalie Harrison Cline, Attorney-in-Fact
Stock symbol
HCA
Transactions as of
Jan 23, 2023
Transactions value $
-$290,700
Form type
4
Date filed
1/25/2023, 06:03 PM
Previous filing
Feb 23, 2022
Next filing
Feb 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Options Exercise $492K +6K +31.39% $81.96 25.1K Jan 23, 2023 Direct F1
transaction HCA Common Stock Tax liability -$782K -2.97K -11.81% $263.81 22.1K Jan 23, 2023 Direct F1
holding HCA Common Stock 60K Jan 23, 2023 By PMP 2020 Trust
holding HCA Common Stock 64K Jan 23, 2023 by RJP 2020 Trust
holding HCA Common Stock 4K Jan 23, 2023 by 2021 Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCA Stock Appreciation Right Options Exercise $0 -6K -32.72% $0.00 12.3K Jan 23, 2023 Common Stock 6K $81.96 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018.